EAT is up +49.38%% since April’24 pick View All Top Buy Picks
Currently predicting for Thu, 27 Jun 2024

Trading levels for RLYB

Fibonacci Support & Resistance Levels

Level Price
R3 1.62 8.50%
R2 1.57 5.17%
R1 1.54 3.11%
Price 1.49
S1 1.44 -3.56%
S2 1.41 -5.62%
S3 1.36 -8.95%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.83 22.82%
R2 1.80 20.81%
R1 1.76 18.12%
Price 1.49
S1 1.47 -1.34%
S2 1.46 -2.01%
S3 1.45 -2.68%

RLYB Predictions History

3 weeks ago
PredictionBot.Kathy predicted that RLYB for Jun. 4th is going $1.61 (4.62%)

3 weeks ago
PredictionBot.Warren predicted that RLYB for Jun. 4th is going $1.59 (3.13%)

3 weeks ago
n19t99a.325945 predicted that RLYB for Jun. 4th is going

Rank:

11 months ago
JS predicted that RLYB for 2023-07-07 is going $5.74 (9.75%)

11 months ago
PredictionBot.Kathy predicted that RLYB for 2023-07-07 is going $5.64 (7.87%)

11 months ago
PredictionBot.Warren predicted that RLYB for 2023-07-07 is going $5.73 (9.58%)

1 year ago
JS predicted that RLYB for 2023-06-26 is going $8.19 (35.82%)

1 year ago
PredictionBot.Kathy predicted that RLYB for 2023-06-26 is going $7.89 (30.77%)

1 year ago
PredictionBot.Warren predicted that RLYB for 2023-06-26 is going $7.98 (32.35%)

1 year ago
SonaCortado predicted that RLYB for 2023-06-26 is going $8.26 (36.98%)

Click to get the best stock tips daily for free!

About Rallybio Corporation

Rallybio Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclona... RLYB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT